I’m sure you are familiar with “direct-to-consumer” advertising — or DTC. That’s what the prescription medical products industry calls the practice of advertising directly to consumers.
The goal of this practice is to get consumers to request a prescription from their physician.
This type of advertising — which has only been going on since the early 1990s — now dominates the airwaves. The most common ads are for drugs that treat “ED,” insomnia, high cholesterol, and allergies. I’m sure you’ve seen them.
Well, I just learned that this same type of advertising is now being used to promote bariatric (weight-loss) surgery. Allergan (a pharmaceutical company) purchased the Lap-Band System from Inamed Health earlier this year and now wants to get the word out.
This type of weight-loss surgery ties a band around the stomach rather than using staples to make the stomach smaller.
This advertising campaign is one of the medical industry’s first TV campaigns for a surgical procedure. It’s a 60 second testimonial spot that will air on both the national networks and national cable stations between now and the end of the year. The ads give a toll-free number to call and a website to visit. A spokesperson for the company said the responses have exceeded expectations.
To be blunt, I don’t agree with this type of advertising. The medical treatment world is hugely complex, so to expect consumers to evaluate and then request a prescription based on a 60 second advertisement is fraught with problems. I’ll discuss these problems in future blogs.
Bariatric surgery is very serious stuff. In fact, in my course on weight loss, I suggest it as the very last thing to consider — and only after exhausting the primary recommendations I offer.
Allen Oelschlaeger
Author of Finally, the Straight Scoop About Weight, Nutrition, and Fitness
